Crescent Biopharma CBIO
NASDAQ CBIO
$14.76 +0.84 (+6.00%)
At close: Nov 11, 2026 · 4:00 PM EST

Crescent Biopharma (CBIO) Revenue (2013 - 2026)

Updated

Analysis

Crescent Biopharma (CBIO) Revenue (2013 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 24.40 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 25.40 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 17.40 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 18.09 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 15.07 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 10.37 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 8.30 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 16.58 Bn
10 Crescent Biopharma 386.36 Mn -320.93 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 1.04 Mn
Dec 31, 2025 1.10 Mn
Sep 30, 2025 1.28 Mn
Sep 30, 2024 184,520.00
Jun 30, 2024 262,288.00
Mar 31, 2024 378,360.00
Dec 31, 2023 512,194.00
Sep 30, 2023 610,978.00
Jun 30, 2023 671,033.00
Mar 31, 2023 581,668.00
Jun 30, 2022 75,000.00
Mar 31, 2022 7,069.00
Dec 31, 2021 17,625.00
Sep 30, 2021 86,560.00
Jun 30, 2021 142.00
Mar 31, 2021 1.06 Mn
Dec 31, 2020 162,935.00
Sep 30, 2020 1.00 Mn
Mar 31, 2020 9.00 Mn
Dec 31, 2019 608,792.00
API Access

Crescent Biopharma Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=CBIO&period=max&api_key=YOUR_API_KEY